SK Biopharm Launches New Innovative Epilepsy Treatment Drug, Cenobamate, in China
SK Biopharm announced on Thursday that its innovative epilepsy drug, Cenobamate (marketed as Yifurui in China), has officially launched in China, with initial prescriptions being filled at major hospitals across the country.This milestone comes appro